These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8100221)

  • 1. Inhibition of acetylcholinesterase by distigmine bromide (Ubretid).
    Breuel HP; Bohn-Olszewsky W; Engelsen SJ; Samhaber EM; Niklaus H
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):230-5. PubMed ID: 8100221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absolute bioavailability, pharmacokinetics, renal and biliary clearance of distigmine after a single oral dose in comparison to i.v. administration of 14C-distigmine-bromide in healthy volunteers.
    Vree TB; Waitzinger J; Hammermaier A; Radhofer-Welte S
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):393-403. PubMed ID: 10475142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic and pharmacodynamic analysis of acetylcholinesterase inhibition by distigmine bromide in rats.
    Ito Y; Harada T; Fushimi K; Kagawa Y; Oka H; Nakazawa H; Homma R; Kato Y; Yamada S
    Drug Metab Pharmacokinet; 2010; 25(3):254-61. PubMed ID: 20610884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
    Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
    Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of food and time of administration on the pharmacokinetic and pharmacodynamic profile of metrifonate.
    Heinig R; Sachse R
    Int J Clin Pharmacol Ther; 1999 Sep; 37(9):456-64. PubMed ID: 10507245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of red blood cell acetylcholinesterase by oral huperzine A against ex vivo soman exposure: next generation prophylaxis and sequestering of acetylcholinesterase over butyrylcholinesterase.
    Haigh JR; Johnston SR; Peppernay A; Mattern PJ; Garcia GE; Doctor BP; Gordon RK; Aisen PS
    Chem Biol Interact; 2008 Sep; 175(1-3):380-6. PubMed ID: 18572153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of distigmine bromide on the central cholinergic system.
    Nakayama K; Katsu H; Kitazumi K
    J Psychopharmacol; 2009 Mar; 23(2):190-3. PubMed ID: 18515453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effects of a series of new pyridinium derivatives against inhibition of acetylcholinesterase by fluostigmine.
    Faff J; Raszewski W; Rump S
    Pharmazie; 1978; 33(2-3):120-1. PubMed ID: 674296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil.
    Periclou AP; Ventura D; Sherman T; Rao N; Abramowitz WT
    Ann Pharmacother; 2004 Sep; 38(9):1389-94. PubMed ID: 15266045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of a single oral dose of tri-o-cresyl phosphate on neurotoxic esterase and acetylcholinesterase activities in the central nervous system, erythrocytes and plasma.
    Barrett DS; Oehme FW
    Vet Hum Toxicol; 1994 Feb; 36(1):1-4. PubMed ID: 8154093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized, crossover, single-blind, placebo-controlled, human pharmacology clinical trial with desoxypeganine, a new cholinesterase and selective MAO-A inhibitor: multiple-dose pharmacokinetics.
    Algorta J; Pena MA; Alvarez A; Maraschiello C; Maruhn D; Windisch M; Mucke HA
    Int J Clin Pharmacol Ther; 2009 Jul; 47(7):483-90. PubMed ID: 19640356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
    Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
    Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testing of antidotes for organophosphorus compounds: experimental procedures and clinical reality.
    Eyer P; Szinicz L; Thiermann H; Worek F; Zilker T
    Toxicology; 2007 Apr; 233(1-3):108-19. PubMed ID: 17010492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.
    Ramael S; De Smedt F; Toublanc N; Otoul C; Boulanger P; Riethuisen JM; Stockis A
    Clin Ther; 2006 May; 28(5):734-44. PubMed ID: 16861095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distigmine Bromide Produces Sustained Potentiation of Guinea-Pig Urinary Bladder Motility by Inhibiting Cholinesterase Activity.
    Obara K; Chino D; Tanaka Y
    Biol Pharm Bull; 2017; 40(6):807-814. PubMed ID: 28566624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HI-6 on cholinesterases and on the cholinergic system of the rat bladder.
    Soukup O; Pohanka M; Tobin G; Jun D; Fusek J; Musilek K; Marek J; Kassa J; Kuca K
    Neuro Endocrinol Lett; 2008 Oct; 29(5):759-62. PubMed ID: 18987577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cholinergic crisis following administration of distigmine bromide: a case report].
    Yamanaka S; Fujita I; Murota T; Kawakita M; Matsuda T
    Hinyokika Kiyo; 2002 Jan; 48(1):21-3. PubMed ID: 11868380
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological activity of pyridinium-type acetylcholinesterase inhibitors.
    Alptüzün V; Kapková P; Baumann K; Erciyas E; Holzgrabe U
    J Pharm Pharmacol; 2003 Oct; 55(10):1397-404. PubMed ID: 14607022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.